Cafepharma Today

May 16 2025 - Novo CEO to depart as obesity drugmaker’s challenges rise
Novo CEO to depart as obesity drugmaker’s challenges rise
BioMarin expands enzyme expertise with $270M Inozyme buy
Amgen could owe Regeneron more than $400M after defeat in cholesterol drug antitrust suit
Eli Lilly collaborates with Rznomics on hearing loss treatment in $1.3 billion pact
*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

Prolor Said to Hire Jefferies to Evaluate Alternatives
Bloomberg
Thursday, April 11, 2013 - 11:32am
tags:
Prolor Biotech, M&A
Bristol-Myers to spend $250 mln to expand biologics facility
Reuters
Thursday, April 11, 2013 - 11:31am
tags:
Bristol-Myers Squibb, biologics, R&D
FDA reviewing pill form of Merck drug to block fungal infections in immune-compromised people
Yahoo/AP
Thursday, April 11, 2013 - 11:29am
tags:
FDA, Merck, antifungals, Noxafil
FDA designates experimental Pfizer drug for common breast cancer type a breakthrough therapy
Yahoo/AP
Thursday, April 11, 2013 - 11:28am
tags:
FDA, Pfizer, breast cancer, palbociclib
VistaGen raises $36M for stem cell tech
Fierce Biotech
Wednesday, April 10, 2013 - 11:33am
tags:
stem cells, VistaGen
St. Jude wins European OK for brain implant to treat Dystonia
Reuters
Wednesday, April 10, 2013 - 11:31am
tags:
St. Jude Medical, Europe, dystonia, brain implants, devices
How the Dow's Pharma Stocks Have Fared in 2013
Motley Fool
Wednesday, April 10, 2013 - 11:29am
tags:
drug stocks
Spectrum Progresses with SPI-2012
Yahoo/Zacks
Wednesday, April 10, 2013 - 11:27am
tags:
Spectrum Pharmaceuticals, SPI-2012, chemotheraphy-induced neutropenia, Amgen
BioDelivery On Track For Mid-Year NDA Filing
Seeking Alpha
Wednesday, April 10, 2013 - 11:22am
tags:
BioDelivery Sciences, Bunavail, opioid addiction
Patients Dosed in Arena Study
Yahoo/Zacks
Wednesday, April 10, 2013 - 11:20am
tags:
Arena Pharmaceuticals, APD334, autoimmune disease
The Vatican / NeoStem Partnership Looks To Create Interest And Advance Cell Therapy
Seeking Alpha
Wednesday, April 10, 2013 - 11:17am
tags:
NeoStem, stem cells, Baxter International, StemCells, Pluristem, Osiris, Neuralstem
Unigene Gets $750K from Victory Park
TheStreet.com
Wednesday, April 10, 2013 - 11:15am
tags:
Unigene
Eli Lilly settles wrongful death lawsuit
Indianapolis Star, IN
Wednesday, April 10, 2013 - 11:14am
tags:
Cymbalta, Eli Lilly, lawsuits
Another State Smacks Down Biosimilar Legislation
Pharmalot
Wednesday, April 10, 2013 - 11:13am
tags:
biosimilars, Maryland
Pfizer’s Palbociclib (PD-0332991) Receives FDA Breakthrough Therapy Designation For Potential Treatment Of Patients With Breast Cancer
Yahoo
Wednesday, April 10, 2013 - 11:10am
tags:
Pfizer, palbociclib, FDA, breast cancer
Astex Pharmaceuticals provides positive update on SGI-110
Yahoo/Fly on the Wall
Wednesday, April 10, 2013 - 11:07am
tags:
Astex, SGI-110, ovarian cancer
Pieris and Sanofi Broaden Existing Collaboration
Yahoo
Wednesday, April 10, 2013 - 11:06am
tags:
Pieris, Sanofi, Anticalins
Where Is Pfizer Heading With The Patent Cliff?
Seeking Alpha
Wednesday, April 10, 2013 - 11:04am
tags:
Pfizer, patents, patent cliff, Acura Pharmaceuticals, Durect Corporation, Pain Therapeutics
Glaxo's Drisapersen Data Revealed Early
TheStreet.com
Tuesday, April 9, 2013 - 4:02pm
tags:
GSK, drisapersen, eteplirsen, Sarepta, Duchenne Muscular Dystrophy
Union sues Warner Chilcott, Watson and Lupin over alleged pay-for-delay deal
Fierce Pharma
Tuesday, April 9, 2013 - 2:51pm
tags:
Watson Pharmaceuticals, Warner Chilcott, unions, pay-for-delay, Lupin

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

Alzheimer's Update: Infectious Agents and Gamma-Secretase Too
In the Pipeline
Obesity Without Metabolic Dysfunction?
In the Pipeline
New Cell Therapy For Resistant Hodgkins Patients
In the Pipeline
Escape From the Lysosome
In the Pipeline
Heavy Water in Your NMR Experiments, And Elsewhere
In the Pipeline
GIPR: Agonists and Antagonists Do the Same Thing, But How
In the Pipeline
Mutant Proteins Classified
In the Pipeline
The Continuing Crisis, Part XIV: The Trumpist Worldview
In the Pipeline
Whole Lotta Snakin' Going On
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.